GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » Net Margin %

Formycon AG (XTER:FYB) Net Margin % : 218.22% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Formycon AG Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Formycon AG's Net Income for the six months ended in Dec. 2023 was €73.99 Mil. Formycon AG's Revenue for the six months ended in Dec. 2023 was €33.91 Mil. Therefore, Formycon AG's net margin for the quarter that ended in Dec. 2023 was 218.22%.

The historical rank and industry rank for Formycon AG's Net Margin % or its related term are showing as below:

XTER:FYB' s Net Margin % Range Over the Past 10 Years
Min: -36.3   Med: -1.02   Max: 97.55
Current: 97.55


XTER:FYB's Net Margin % is ranked better than
98.06% of 1029 companies
in the Biotechnology industry
Industry Median: -154.15 vs XTER:FYB: 97.55

Formycon AG Net Margin % Historical Data

The historical data trend for Formycon AG's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formycon AG Net Margin % Chart

Formycon AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.92 -19.62 -36.30 84.69 97.55

Formycon AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.23 453.59 -177.20 4.12 218.22

Competitive Comparison of Formycon AG's Net Margin %

For the Biotechnology subindustry, Formycon AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formycon AG's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formycon AG's Net Margin % distribution charts can be found below:

* The bar in red indicates where Formycon AG's Net Margin % falls into.



Formycon AG Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Formycon AG's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=75.795/77.696
=97.55 %

Formycon AG's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=73.991/33.907
=218.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Formycon AG  (XTER:FYB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Formycon AG Net Margin % Related Terms

Thank you for viewing the detailed overview of Formycon AG's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Formycon AG (XTER:FYB) Business Description

Traded in Other Exchanges
Address
Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID 19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.
Executives
Dr. Stefan Glombitza Board of Directors
Dr. Carsten Brockmeyer Board of Directors
Dr. Nicolas Combé Board of Directors

Formycon AG (XTER:FYB) Headlines

No Headlines